Humana said its diluted earnings per share (EPS) for Q2 2024 (2Q24) was $5.62 on a GAAP basis and $6.96 on an Adjusted basis, and that for 2Q23 it was $7.66 on a GAAP basis and $8.94 on an Adjusted basis.

1. 01

   Humana said its diluted earnings per share (EPS) for Q2 2024 (2Q24) was $5.62 on a GAAP basis and $6.96 on an Adjusted basis, and that for 2Q23 it was $7.66 on a GAAP basis and $8.94 on an Adjusted basis.

2. 02

   The company said it revised its GAAP EPS guidance for FY 2024 to approximately $12.81 from approximately $13.93, while affirming its Adjusted EPS guidance of approximately $16.00.

3. 03

   The company said its consolidated benefits expense ratio was 89.0% for 2Q24, compared with 86.3% for 2Q23, and its consolidated operating cost ratio was 10.8%, compared with 11.8% for 2Q23.

4. 04

   The company said operating cash flows for the 6 months year to date in 2024 were $1,636 million, and that GAAP and Adjusted operating cash flows for the year-to-date period in 2023 were $9,863 million and $2,861 million, respectively, with the adjustment for the timing of CMS premium payments at $7,002 million.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.